Extensive nuclear localization of α-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody

Neuroscience

Volumn 145, Issue 2, 2007, Pages 539-555

  Yu, S ^a   Li, X ^a   Liu, G ^a   Han, J ^a   Zhang, C ^b   Li, Y ^a   Xu, S ^a   Liu, C ^c   Gao, Y ^c   Yang, H ^b   Ueda K ^a,d   Chan, P ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

synuclein; monoclonal antibody; neuron; nucleus; rat

Indexed keywords

ALPHA SYNUCLEIN; AMINO ACID; BRAIN PROTEIN; COLLOIDAL GOLD; EPITOPE; GOLD; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2E3; MONOCLONAL ANTIBODY 3D5; PEPTIDE; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN NERVE CELL; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR PROBE; MOLECULAR RECOGNITION; MOLECULAR SIZE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SYNAPTOSOME; WESTERN BLOTTING; WISTAR RAT;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BRAIN; CELL NUCLEUS; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, IMMUNOELECTRON; NEURONS; PRESYNAPTIC TERMINALS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR;

EID: 33847649977     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.12.028     Document Type: Article

References (59)

1. Alim M.A., Hossain M.S., Arima K., Takeda K., Izumiyama Y., Nakamura M., Kaji H., Shinoda T., Hisanaga S., and Uéda K. Tubulin seeds alpha-synuclein fibril formation. J Biol Chem 277 (2002) 2112-2117
2. Alim M.A., Ma Q.L., Takeda K., Aizawa T., Matsubara M., Nakamura M., Asada A., Saito T., Kaji H., Yoshii M., Hisanaga S., and Uéda K. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J Alzheimers Dis 6 (2004) 435-442
3. Arima K., Uéda K., Sunohara N., Hirai S., Izumiyama Y., Tonozuka-Uehara H., and Kawai M. Immunoelectron microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808 (1998) 93-100
4. Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., and Kawai M. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol (Berl) 96 (1998) 439-444
5. Arima K., Mizutani T., Alim M.A., Tonozuka-Uehara H., Izumiyama Y., Hirai S., and Uéda K. NACP/alpha-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies. Acta Neuropathol (Berl) 100 (2000) 115-121
6. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., and Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152 (1998) 879-884
7. Baptista M.J., O'Farrell C., Daya S., Ahmad R., Miller D.W., Hardy J., Farrer M.J., and Cookson M.R. Co-ordinate transcriptional regulation of dopamine synthesis genes by α-synuclein in human neuroblastoma cell lines. J Neurochem 85 (2003) 957-968
8. Bayer T.A., Jakala P., Hartmann T., Egensperger R., Buslei R., Falkai P., and Beyreuther K. Neural expression profile of alpha-synuclein in developing human cortex. Neuroreport 10 (1999) 2799-2803
9. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., and Williamson R.E. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97 (2000) 571-576
10. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Harper J.D., Williamson R.E., and Lansbury Jr. P.T. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann N Y Acad Sci 920 (2000) 42-45
11. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
12. Dickson D.W., Liu W., Hardy J., Farrer M., Mehta N., Uitti R., Mark M., Zimmerman T., Golbe L., Sage J., Sima A., D'Amato C., Albin R., Gilman S., and Yen S. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 155 (1999) 1241-1251
13. Dickson D.W., Lin W., Liu W.K., and Yen S.H. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 9 (1999) 721-732
14. Feany M.B., and Bender W.W. A Drosophila model of Parkinson's disease. Nature 404 (2000) 394-398
15. Forman M.S., Trojanowski J.Q., and Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10 (2004) 1055-1063
16. Gai W.P., Power J.H., Blumbergs P.C., and Blessing W.W. Multiple-system atrophy: a new alpha-synuclein disease?. Lancet 352 (1998) 547-548
17. Galvin J.E., Schuck T.M., Lee V.M., and Trojanowsky J.Q. Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra. Exp Neurol 168 (2001) 347-355
18. George J.M. The synucleins. Genome Biol 3 (2002) REVIEWS3002
19. George J.M., Jin H., Woods W.S., and Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15 (1995) 361-372
20. Goers J., Manning-Bog A.B., McCormack A.L., Millett I.S., Doniach S., DiMonte D.A., Uversky V.N., and Fink A.L. Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 42 (2003) 8465-8471
21. Hamilton R.L. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10 (2000) 378-384
22. Hegde M.L., and Jagannatha Rao K.S. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease. Arch Biochem Biophys 418 (2003) 169-178
23. Hsu L.J., Mallory M., Xia Y., Veinbergs I., Hashimoto M., Yoshimoto M., Thal L.J., Saitoh T., and Masliah E. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. J Neurochem 7 (1998) 338-344
24. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A., Kittel A., and Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995) 467-475
25. Jakes R., Spillantini M.G., and Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 345 (1994) 27-32
26. Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Schindzielorz A., Okochi M., Leimer U., van Der Putten H., Probst A., Kremmer E., Kretzschmar H.A., and Haass C. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J Neurosci 20 (2000) 6365-6373
27. Kaufmann H., Hague K., and Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology 56 (2001) 980-981
28. Krüger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18 (1998) 106-108
29. Lee S.S., Kim Y.M., Junn E., Lee G., Park K.H., Tanaka M., Ronchetti R.D., Quezado M.M., and Mouradian M.M. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Neurobiol Aging 24 (2003) 687-696
30. Leng Y., Chase T.N., and Bennet M.C. Muscarinic receptor stimulation induces translocation of an alpha-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm. J Biol Chem 30 (2001) 28212-28218
31. Li J.Y., Henning Jensen P., and Dahlstrom A. Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. Neuroscience 113 (2002) 463-478
32. Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St. George-Hyslop P., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.M., Iwatsubo T., and Trojanowski J.Q. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153 (1998) 1365-1370
33. Lundvig D., Lindersson E., and Jensen P.H. Pathogenic effects of alpha-synuclein aggregation. Brain Res Mol Brain Res 134 (2005) 3-17
34. Ma Q.L., Chan P., Yoshii M., and Uéda K. Alpha-synuclein aggregation and neurodegenerative diseases. J Alzheimers Dis 5 (2003) 139-148
35. Maroteaux L., Campanelli J.T., and Scheller R.H. Synuclein: a neuronspecific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8 (1988) 2804-2815
36. Maroteaux L., and Scheller R.H. The rat brain synucleins: family of proteins transiently associated with neuronal membrane. Brain Res Mol Brain Res 11 (1991) 335-343
37. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
38. McLean P.J., Ribich S., and Hyman B.T. Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations. J Neural Transm Suppl 58 (2000) 53-63
39. McLean P.J., Kawamata H., Ribich S., and Hyman B.T. Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J Biol Chem 275 (2000) 8812-8816
40. Mori F., Tanji K., Yoshimoto M., Takahashi H., and Wakabayashi K. Immuno-histochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. Brain Res 94 (2002) 118-126
41. Moussa C.E., Wersinger C., Tomita Y., and Sidhu A. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry 43 (2004) 5539-5550
42. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego
43. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di I.G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
44. Specht C.G., Tigaret C.M., Rast G.F., Thalhammer A., Rudhard Y., and Schoepfer R. Subcellular localisation of recombinant alpha- and gamma-synuclein. Mol Cell Neurosci 28 (2005) 326-334
45. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. α-Synuclein in Lewy bodies. Nature 388 (1997) 839-840
46. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95 (1998) 6469-6473
47. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., and Masliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 152 (1998) 367-372
48. Tanji K., Mori F., Imaizumi T., Yoshida H., Matsumiya T., Tamo W., Yoshimoto M., Odagiri H., Sasaki M., Takahashi H., Satoh K., and Wakabayashi K. Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. Pathol Int 52 (2002) 572-577
49. Tofaris G.K., and Spillantini M.G. Alpha-synuclein dysfunction in Lewy body diseases. Mov Disord 20 Suppl 12 (2005) S37-S44
50. Tu P.H., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J.Q., and Lee V.M. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44 (1998) 415-422
51. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., and Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 90 (1993) 11282-11286
52. Wakabayashi K., Yoshimoto M., Tsuji S., and Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249 (1998) 180-182
53. Xu J., Kao S.Y., Lee F.J.S., Song W., Jin L.W., and Yankner B.A. Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8 (2002) 600-606
54. Yamada M., Iwatsubo T., Mizuno Y., and Mochizuki H. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. J Neurochem 91 (2004) 451-461
55. Yu S., Zhao T., Fan M., Tooyama I., Kimura H., and Renda T.G. Production of monoclonal antibody to deltorphin-I and its immunocytochemical application to adult rat brain and cultured rat brain neurons. Peptides 21 (2000) 1657-1662
56. Yu S., Zuo X., Li Y., Zhang C., Zhou M., Zhang Y.A., Uéda K., and Chan P. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett 367 (2004) 34-39
57. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., and de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55 (2004) 164-173
58. Zhou W., Hurlbert M.S., Schaack J., Prasad K.N., and Freed C.R. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res 866 (2000) 33-43
59. Zhou Z.D., Yap B.P., Gung A.Y., Leong S.M., Ang S.T., and Lim T.M. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein. Exp Cell Res 312 (2006) 156-170